Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.98x is 75% below its 5-year average of 11.77x, around the middle of its 5-year range (-33.48x–44.60x).
64.23% below its 12-month average of 8.33x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 22.96x.
INTEREST COVERAGE RATIO
2.98x
INTEREST COVERAGE RATIO AVG TTM
8.33x
INTEREST COVERAGE RATIO AVG 3Y
5.19x
INTEREST COVERAGE RATIO AVG 5Y
11.77x
INTEREST COVERAGE RATIO AVG 10Y
6.30x
INTEREST COVERAGE RATIO AVG 15Y
11.87x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-64.23%
CURRENT VS 3Y AVG
-42.61%
CURRENT VS 5Y AVG
-74.68%
CURRENT VS 10Y AVG
-52.73%
CURRENT VS 15Y AVG
-74.90%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+146.27%
vs the sector median at left
Omnicell, Inc.
Market Cap
$1.61B
Interest Coverage Ratio
2.98x
TTM Avg
8.33x
3Y Avg
5.19x
5Y Avg
11.77x
Market Cap
$1.61B
Interest Coverage Ratio
-22.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.62B
Interest Coverage Ratio
-3.88x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$1.60B
Interest Coverage Ratio
-3.03x
TTM Avg
41.56x
3Y Avg
41.56x
5Y Avg
41.56x
Market Cap
$1.63B
Interest Coverage Ratio
4.05x
TTM Avg
2.04x
3Y Avg
1.94x
5Y Avg
1.94x
Market Cap
$1.59B
Interest Coverage Ratio
-17.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Interest Coverage Ratio
-2287.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54B
Interest Coverage Ratio
-8.08x
TTM Avg
13.81x
3Y Avg
13.81x
5Y Avg
13.81x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omnicell, Inc. (OMCL) | $1.61B | 2.98x | 8.33x | 5.19x | 11.77x |
| Septerna Inc (SEPN)vs › | $1.61B | N/A | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -22.82x | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | -3.88x | 0.61x | 0.61x | 0.61x |
| uniQure N.V. (QURE)vs › | $1.60B | -3.03x | 41.56x | 41.56x | 41.56x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 4.05x | 2.04x | 1.94x | 1.94x |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -17.85x | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -2287.78x | N/A | N/A | N/A |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -8.08x | 13.81x | 13.81x | 13.81x |
| Innoviva, Inc. (INVA)vs › | $1.54B | 9.81x | 8.66x | 9.09x | 12.26x |
Interest Coverage
3.0x
Debt/Equity
0.15
Current Ratio
1.64
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 22.96x |
| 2025-12-31 | 0.48x |
| 2025-09-30 | 28.43x |
| 2025-06-30 | 23.27x |
| 2025-03-31 | -33.48x |
| 2024-12-31 | 12.38x |
| 2024-09-30 | 6.31x |
| 2024-06-30 | 2.84x |
| 2024-03-31 | -16.45x |
| 2022-09-30 | 16.38x |
| 2022-06-30 | 11.10x |
| 2022-03-31 | 44.60x |
| 2021-12-31 | 2.04x |
| 2021-09-30 | 5.22x |
| 2021-06-30 | 5.20x |
| 2020-12-31 | 3.19x |
| 2020-09-30 | 11.64x |
| 2020-06-30 | -34.95x |
| 2019-12-31 | 104.63x |
| 2019-09-30 | 17.60x |
| 2019-03-31 | 6.81x |
| 2018-06-30 | 8.19x |
| 2017-12-31 | 9.56x |
| 2017-09-30 | 3.56x |
| 2017-06-30 | -12.27x |
| 2017-03-31 | -7.02x |
| 2016-12-31 | -0.11x |
| 2016-09-30 | 1.81x |
| 2016-06-30 | -0.06x |
| 2016-03-31 | 0.85x |
| 2015-12-31 | 15.90x |
| 2015-09-30 | 21.45x |
| 2015-06-30 | 26.32x |
| 2015-03-31 | 20.08x |
| 2014-12-31 | 177.29x |
| 2014-09-30 | 19.26x |
| 2014-06-30 | 313.95x |
| 2014-03-31 | 38.88x |
| 2013-09-30 | 428.68x |
| 2013-06-30 | 148.56x |
| 2013-03-31 | 18.70x |
| 2012-12-31 | 1087.89x |
| 2012-09-30 | 330.18x |
| 2012-06-30 | 33.30x |
| 2011-12-31 | -82.25x |
| 2011-09-30 | 25.10x |
| 2010-09-30 | 18.89x |
| 2009-06-30 | 6.79x |
| 2008-09-30 | 6.26x |
| 2008-06-30 | 6.24x |
| 2008-03-31 | 3.45x |
